Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostic Reagent	293.23M	-	-						177.91M	122.46M
Diagnostic Instruments	13.53M	-	-						6.41M	5.27M
Testing Services	6.10M	-	-						96.25K	-
Other	17.95K	-	-						-	-
Software	-	-	-						45.30K	269.23K
Total	312.87M	-	-						184.47M	128.00M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Northeast China	14.10M	-	-
North China	26.31M	-	-
East China	140.13M	-	-
South China	35.60M	-	-
Central China	31.89M	-	-
Northwest China	24.15M	-	-
Southwest China	27.51M	-	-
Hong Kong, Macau and Taiwan	3.63K	-	-
Foreign	13.17M	-	-
Total	312.87M	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error